Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P246. Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease
P246. Technical performance of a novel adsorptive type cytapheresis module in patients with moderately to severely active ulcerative colitis
P246

Intracavitary contrast-enhanced ultrasound in evaluating fistula of Crohn's Disease: a preliminary study

Authors:

Y.-j. Chen*1, R. Mao2, Y. He2, B.-l. Chen2, Z.-r. Zeng2, X.-y. Xie1, M.-h. Chen2

1First Affiliated Hospital of Sun Yat-sen University, Department of Medical Ultrasonics, Guangzhou, China, 2First Affiliated Hospital of Sun Yat-Sen University, Department of Gastroenterology, Guangzhou, China

P247.

Development of a new tool to assess Crohn's disease magnetic resonance inflammation severity

Authors:

Y. Bouhnik1, M. Zappa2, V. Abitbol3, M. Lewin4, M. Boudiaf5, J. Cosnes6, J.Y. Mary7, 1Hopital Beaujon, Gastro Enterologie Nurtition, France, France, 2Hopital Beaujon, Radiologie, Clichy, France, 3Hôpital Cochin, Gastroenterology, Paris, France, 4Hopital Paul Brousse, Imagerie, Villejuif, France, 5Hopital Larioboisiere, Imagerie, Paris, France, 6Hopital Saint Antoine, Gastro Enterologie, Paris, France, 7Hopital Saint Louis, SBIM, Paris, France

P247. Evaluating small bowel disease activity in Crohn's disease: new evidence on the correlation between endoscopic scoring systems and CRP
Authors:

F. Dias de Castro1, B. Rosa1, J. Magalhães1, M.J. Moreira1, J. Cotter1, 1Centro Hospitalar Alto Ave, Gastroenterology, Guimarães, Portugal

P247. Iron status and treatment of iron deficiency with ferric carboxymaltose in IBD patients: A retrospective, single center analysis
P247. Uptake in the UK of vaccination recommendations in inflammatory bowel disease (IBD)
P247

C-reactive protein is elevated with clinical disease activity during pregnancy in women with Inflammatory Bowel Disease

Authors:

J. Bal, R. Foshaug, L. Ambrosio, K.I. Kroeker, L. Dieleman, B. Halloran, R.N. Fedorak, V.W. Huang*

University of Alberta, Gastroenterology, Edmonton, Canada

P248.

Cryptogenic multifocal ulcerating stenosing enteritis (CMUSE): to be differentiated from Crohn's disease

Authors:

H. Ooms, H. De Schepper, E. Macken, P. Pelckmans, T. Moreels, Antwerp University Hospital, Antwerp, Belgium, Gastroenterology & Hepatology, Edegem – Antwerp, Belgium

P248. Endoscopic evaluation of colonic mucosa in ulcerative colitis patients in clinical remission
Authors:

O. Shchukina1, E. Kondrashina2, O. Orlov3, A. Vladimirova4, A. Botina5, E. Markova6, A. Kharitidis7, 1North-West State Medical University, Chair of Gastroenterology and Dietology, Saint-Petersburg, Russian Federation, 2North-West State University, Chair of Gastroenterology and Dietology, Saint-Petersburg, Russian Federation, 3City clinical hospital #3, Saint-Petersburg, Russian Federation, 4Irkutsk Diagnostic Center, Irkutsk, Russian Federation, 5Saint-Petersburg state medical university named after I.P. Pavlov, Saint-Petersburg, Russian Federation, 6City clinical hospital #31, Saint-Petersburg, Russian Federation, 7City Clinical Hospital #31, City Centre of IBD, Saint-Petersburg, Russian Federation

P248. Infliximab in steroid-dependent ulcerative colitis: Efficacy and predictors of clinical and endoscopic remission
P248. Perceptions of the risks of continuation and cessation of maintenance therapy among patients with inflammatory bowel disease
P248

Non-invasive Methods for monitoring mucosal healing in paediatric ulcerative colitis with usage of faecal calprotectin.

Authors:

M. Meglicka, M. Szczepanski, M. Dadalski, J. Kierkus*

The Children's Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, Warsaw, Poland

P249.

Cross sectional imaging techniques data compared to per-operative data in patients with Crohn's disease

Authors:

N. Ben Mustapha, Y. Kardous, M. Serghini, A. Labidi, M. Fekih, J. Boubaker, A. Filali, La Rabta Hospital, Gastroenterology A, Tunis, Tunisia

P249. A real life retrospective analysis of drug expenditure reveals no significant cost difference between infliximab and adalimumab in the treatment of adult Crohn's disease
P249. Combination therapy with infliximab and thiopurines might reduce colectomy rates compared to infliximab monotherapy in patients with ulcerative colitis (UC)
P249. Endoscopic extension of inflammation progresses more frequently in ulcerative colitis compared to Crohn's disease patients
Authors:

K. Katsanos1, V. Tsianos1, T. Vasileiou1, A. Tatsioni2, D. Sigounas1, I. Mitselos1, D. Christodoulou1, E. Tsianos1, for the NW Greece IBD Study Group, 1University of Ioannina, Ioannina, Greece, 2Department of Family Medicine University of Ioanninaand Tufts-New England Medical Center Evidence-Based Practice Center, Institute for Clinical Research and Health Policy Studies, Boston, USA, Greece

P249

Worries in IBD patient relatives. Why and how much do they worry?

Authors:

E. Berroa, L. Fernández-Salazar*, B. Velayos, A. Macho, N. Alcaide, J.M. González

Hospital Clínico Universitario, Gastroenterology, Valladolid, Spain

P250.

Correlation of faecal calprotectin levels with Crohn's disease activity scores using two different immunoassays

Authors:

M. Oyaert1, D. De Smet1, F. Baert2, F. D'Heygere3, N. Callewaert4, M. Langlois5, H. Vanpoucke1, 1AZ Delta Roeselare Menen, Clinical Laboratory, Roeselare, Belgium, 2AZ Delta Roeselare Menen, Gastroenterology, Roeselare, Belgium, 3AZ Groeninge, Gastroenterology, Kortrijk, Belgium, 4AZ Groeninge, Clinical Laboratory, Kortijk, Belgium, 5AZ St. Jan Brugge Oostende, Laboratory Medicine, Brugge, Belgium

P250. Elevated faecal calprotectin predicts disease progression in Crohn's disease
Authors:

N.A. Kennedy1, J. Chang2, M.H. Guy2, T. Smith2, J.T. Loh2, D. Haunschmidt2, M. Muscat2, F. Fascí Spurio2, H.E. Drummond1, K. Kingstone3, C.L. Noble2, A.G. Shand2, J. Satsangi1, I.D. Arnott2, C.W. Lees2, 1Western General Hospital, Gastointestinal Unit, Molecular Medicine Centre, Edinburgh, United Kingdom, 2Western General Hospital, Department of Gastroenterology, Edinburgh, United Kingdom, 3Western General Hospital, Department of Clinical Biochemistry, Edinburgh, United Kingdom